Lead SARS-CoV-2 Candidate Vaccines: Expectations from Phase III Trials and Recommendations Post-Vaccine Approval

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is transmitted primarily through respiratory droplets/aerosols and it causes COVID-19. The virus infects epithelial cells by using the spike protein on its surface to bind to angiotensin-converting enzyme 2 receptor on the cells. Thus, can...

Descripción completa

Detalles Bibliográficos
Autor principal: Tumban, Ebenezer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824305/
https://www.ncbi.nlm.nih.gov/pubmed/33396343
http://dx.doi.org/10.3390/v13010054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824305/
https://www.ncbi.nlm.nih.gov/pubmed/33396343
http://dx.doi.org/10.3390/v13010054

Ejemplares similares